Growth Hormone (rat) ELISA kit

PRODUCT EXPLANATION: ACETYLCHOLINESTERASE MARKER IN ENZYME-IMMUNOASSAYS|Grassi J., Pradelles P. Compounds labelled by the acetylcholinesterase of Electrophorus Electricus. Its preparation process and its use as a tracer or marquer in enzymo-immunological determinations. United States patent, N° 1,047,330. September 10, 1991|Grassi J., Pradelles P. The use of Acetylcholinesterase as a Universal marker in Enzyme-Immunoassays. Proceedings of the Third International Meeting on Cholinesterases, American Chemical Society (1991)|Pradelles P., Grassi J., Maclouf J. Enzyme Immunoassays of Eicosanoids Using Acetylcholinesterase. Methods in Enzymology (1990), vol. 187, 24-34|PRODUCT EXPLANATION: GROWTH HORMONE|Bertherat J., Bluet-Pajot M.T., Epelbaum J. N. Neuroendocrine regulation of growth hormone. Eur J. Endocrinol (1995) Jan;132(1):12-24|Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev. 1998 Dec;19(6):717-97|PRODUCT EXPLANATION: GROWTH HORMONE KIT DEVELOPMENT|Ezan E., Laplante E., Bluet-Pajot M.-T. et al. An Enzyme Immunoassay for rat growth hormone: validation and application to the determination of plasma levels and in vitro release. J. Immunoassay, 18(4), 335-336, 1997|Valentin MA, Ma S, Zhao A, Legay F, Avrameas A. Validation of immunoassay for protein biomarkers: Bioanalytical study plan implementation to support pre-clinical and clinical studies. J Pharm Biomed Anal. (2011) 55(5) : 869-877|European Medicines Agency. Guideline on bioanalytical method validation, 21 July 2011|PRODUCT CITATIONS|Fukuda T., Tanaka T., Hamaguchi Y. et al. Augmented Growth Hormone Secretion and Stat3 Phosphorylation in an Aryl Hydrocarbon Receptor Interacting Protein (AIP)-Disrupted Somatotroph Cell Line. PLoS One. 2016 Oct 5;11(10):e0164131|Pietra C, Takeda Y, Tazawa-Ogata N et al. Anamorelin HCl (ONO-7643), a novel ghrelin receptor agonist, for the treatment of cancer anorexia-cachexia syndrome: preclinical profile. J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):329-37|Domínguez Mancera B, Monjaraz Guzman E, Flores-Hernández JLV et al. Potassium Current Is Not Affected by Long-Term Exposure to Ghrelin or GHRP-6 in Somatotropes GC Cells. Journal of Biophysics 2013(1):913792, February 2013|Ariyasu H, Iwakura H, Yamada G et al. A postweaning reduction in circulating ghrelin temporarily alters growth hormone (GH) responsiveness to GH-releasing hormone in male mice but does not affect somatic growth. Endocrinology. 2010 Apr;151(4):1743-50.|Lu S.L., Callahan S.M., and Brunner L.J. Suppression of Hepatic CYP3A1/2 and CYP2C11 by Cyclosporine Is Not Mediated by Altering Growth Hormone Levels. J Pharmacol Exp Ther. 2003 Apr;305(1):331-7|Silha J.V., Gui Y., Mishra S. et al. Overexpression of Gly56/Gly80/Gly81-Mutant Insulin-Like Growth Factor-Binding Protein-3 in Transgenic Mice. Endocrinology, March 2005, 146(3):1523–1531|Ma J.N., Schiffer H.H., Knapp A.E. et al. Identification of the Atypical L-Type Ca2+ Channel Blocker Diltiazem and Its Metabolites As Ghrelin Receptor Agonists. Mol Pharmacol. 2007 Aug;72(2):380-6. Epub 2007 May 2